mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

Tolerance, Danger, and the Extended Family

Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information

Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604

Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging

Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513

Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964

Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929

IRF Family of Transcription Factors as Regulators of Host Defense

Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658

Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378

Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo

den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319

Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling

Zhang, Q., & Yoo, D. (2016) · Virus Research · doi:10.1016/j.virusres.2016.05.015 · Cited by 123

Mitochondrial Double‐Stranded RNA in Exosome Promotes Interleukin‐17 Production Through Toll‐Like Receptor 3 in Alcohol‐associated Liver Injury

Lee, J. H., Shim, Y., Seo, W., Kim, M., Choi, W., Kim, H., Kim, Y. E., Yang, K., Ryu, T., Jeong, J., et al. (2019) · Hepatology · doi:10.1002/hep.31041 · Cited by 122

Structural and Functional Analyses of the Human Toll-like Receptor 3

Sun, J., Duffy, K. E., Ranjith-Kumar, C. T., Xiong, J., Lamb, R. J., Santos, J., Hema, M., Cunningham, M., Holzenburg, A., Sarisky, R. T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510442200 · Cited by 125

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse

Mohammad, M. K., Morran, M. P., Slotterbeck, B. D., Leaman, D. W., Sun, Y., von Grafenstein, H., Hong, S., & McInerney, M. F. (2006) · International Immunology · doi:10.1093/intimm/dxl045 · Cited by 126

Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS?

Downes, C., & Crack, P. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00864.x · Cited by 124

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice

Chatterjee, P., Weaver, L., Doersch, K., Kopriva, S. E., Chiasson, V. L., Allen, S. J., Narayanan, A. M., Young, K. J., Jones, K. A., Kuehl, T. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041884 · Cited by 123

Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

Broos, K., Van der Jeught, K., Puttemans, J., Goyvaerts, C., Heirman, C., Dewitte, H., Verbeke, R., Lentacker, I., Thielemans, K., & Breckpot, K. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.38 · Cited by 121

Impaired Wound Healing with Defective Expression of Chemokines and Recruitment of Myeloid Cells in TLR3-Deficient Mice

Lin, Q., Fang, D., Fang, J., Ren, X., Yang, X., Wen, F., & Su, S. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003007 · Cited by 124

Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity

Lee, R. H., Yoon, N., Reneau, J. C., & Prockop, D. J. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.10.001 · Cited by 121

mRNA therapeutics deliver a hopeful message

Zhong, Z., Cafferty, S. M., Combes, F., Huysmans, H., Temmerman, J. D., Gitsels, A., Vanrompay, D. C. G., Catani, J. P., & Sanders, N. N. (2018) · Nano Today · doi:10.1016/j.nantod.2018.10.005 · Cited by 124

Effects of Length and Location on the Cellular Response to Double-Stranded RNA

Wang, Q., & Carmichael, G. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.432-452.2004 · Cited by 124

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome

Clarke, G. A., McKernan, D. P., Gaszner, G., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00090 · Cited by 123

The role of Toll‐like receptors in CNS response to microbial challenge

Konat, G. W., Kielian, T., & Marriott, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04076.x · Cited by 123

Tumor vaccination using messenger RNA: prospects of a future therapy

Kreiter, S., Diken, M., Selmi, A., Türeci, Ö., & Şahin, U. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.007 · Cited by 120

Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

Goto, Y., Arigami, T., Kitago, M., Nguyen, S. L., Narita, N., Ferrone, S., Morton, D. L., Irie, R. F., & Hoon, D. S. �. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0582 · Cited by 118

The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism

Farrugia, M., & Baron, B. (2017) · International Journal of Inflammation · doi:10.1155/2017/8391230 · Cited by 119

Danger signals: a time and space continuum

Škoberne, M., Beignon, A., & Bhardwaj, N. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.001 · Cited by 118

Innate Immunity and Organ Transplantation: The Potential Role of Toll-like Receptors

Andrade, C., Waddell, T. K., Keshavjee, S. H., & Liu, M. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00829.x · Cited by 117

Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?

Panzarini, E., Inguscio, V., & Dini, L. (2012) · BioMed Research International · doi:10.1155/2013/482160 · Cited by 120

Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk

Kutikhin, A. G. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.07.307 · Cited by 118

Epithelia: lymphocyte interactions in the gut

Dahan, S., Roth‐Walter, F., Arnaboldi, P. M., Agarwal, S., & Mayer, L. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00484.x · Cited by 120

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

Youn, H., & Chung, J.-K. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1057563 · Cited by 114

Chemically modified RNA activated matrices enhance bone regeneration

Elangovan, S., Khorsand, B., Do, A., Hong, L., Dewerth, A., Kormann, M., Ross, R. D., Sumner, D. R., Allamargot, C., & Salem, A. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.050 · Cited by 114

Nucleic acids and endosomal pattern recognition: how to tell friend from foe?

Brencicova, E., & Diebold, S. S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00037 · Cited by 118

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

Takii, Y., Nakamura, M., Ito, M., Yokoyama, T., Komori, A., Shimizu‐Yoshida, Y., Nakao, R., Kusumoto, K., Nagaoka, S., Yano, K., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700285 · Cited by 114

Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury

Kuipers, M. T., van der Poll, T., Schultz, M. J., & Wieland, C. W. (2011) · Critical Care · doi:10.1186/cc10437 · Cited by 117

RNA Mediated toll-like receptor stimulation in health and disease

Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112

Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice

Stokes, J. A., Cheung, J., Eddinger, K. A., Corr, M., & Yaksh, T. L. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-148 · Cited by 112

Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis

Lundberg, A. M., Ketelhuth, D. F. J., Johansson, M. E., Gerdes, N., Liu, S., Yamamoto, M., Akira, S., & Hansson, G. K. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt033 · Cited by 110

Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo

Dong, Y., Dorkin, J. R., Wang, W., Chang, P., Webber, M. J., Tang, B. C., Yang, J., Ionita, I. A., Danino, D., DeRosa, F., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b02428 · Cited by 111

Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections

Lin, L. C. W., Chattopadhyay, S., Lin, J., & Hu, C. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701395 · Cited by 109

Toll-like receptors: emerging concepts in kidney disease

Anders, H., & Schlöndorff, D. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32803fb767 · Cited by 111

An overview of rational design of mRNA-based therapeutics and vaccines

To, K. K. W., & Cho, W. C. S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1935859 · Cited by 110

Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance

Chin, A. I., Miyahira, A. K., Covarrubias, A. J., Teague, J., Guo, B., Dempsey, P. W., & Cheng, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1162 · Cited by 110

Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles

Baba, M., Itaka, K., Kondo, K., Yamasoba, T., & Kataoka, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.017 · Cited by 109

Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope

Aslan, C., Kiaie, S. H., Zolbanin, N. M., Lotfinejad, P., Ramezani, R., Kashanchi, F., & Jafari, R. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00683-w · Cited by 113

Polyinosinic Acid Is a Ligand for Toll-like Receptor 3

Marshall-Clarke, S., Downes, J. E., Haga, I. R., Bowie, A., Borrow, P., Pennock, J. L., Grencis, R. K., & Rothwell, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700188200 · Cited by 108

TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons

Gao, D., Ciancanelli, M. J., Zhang, P., Harschnitz, O., Bondet, V., Hasek, M. L., Chen, J., Mu, X. N., Itan, Y., Cobat, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci134529 · Cited by 114

Antitumor Immunity by Magnetic Nanoparticle-Mediated Hyperthermia

Kobayashi, T., Kakimi, K., Nakayama, E., & Jimbow, K. (2014) · Nanomedicine · doi:10.2217/nnm.14.106 · Cited by 110

Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors

Tsan, M., & Gao, B. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907078604 · Cited by 111

Necrosis is associated with IL-6 production but apoptosis is not

Berghe, T. V., Kalai, M., Denecker, G., Meeus, A., Saelens, X., & Vandenabeele, P. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.003 · Cited by 105

Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration

Tammaro, A., Kers, J., Scantlebery, A. M. L., & Florquin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01346 · Cited by 105

Neo-Antigen mRNA Vaccines

Esprit, A., de Mey, W., Shahi, R. B., Thielemans, K., Franceschini, L., & Breckpot, K. (2020) · Vaccines · doi:10.3390/vaccines8040776 · Cited by 112

Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases

Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104

Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease

Keene, C. D., Cudaback, E., Li, X., Montine, K. S., & Montine, T. J. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.08.002 · Cited by 103

Repair of the Peripheral Nerve—Remyelination that Works

Svenningsen, Å. F., & Dahlin, L. B. (2013) · Brain Sciences · doi:10.3390/brainsci3031182 · Cited by 103

Innate Immune Sensing of Influenza A Virus

Malik, G., & Zhou, Y. (2020) · Viruses · doi:10.3390/v12070755 · Cited by 114

Manifold Mechanisms of Toll-Like Receptor-Ligand Recognition

Ishii, K. J., Coban, C., & Akira, S. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-7829-1 · Cited by 102

Danger Signaling in Atherosclerosis

Zimmer, S., Grebe, A., & Latz, E. (2015) · Circulation Research · doi:10.1161/circresaha.116.301135 · Cited by 106

Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells

Alvarez-Carbonell, D., García‐Mesa, Y., Milne, S., Das, B., Dobrowolski, C. N., Rojas, R. E., & Karn, J. (2017) · Retrovirology · doi:10.1186/s12977-017-0335-8 · Cited by 97

The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments

Hagerman, R. J., Rivera, S. M., & Hagerman, P. J. (2008) · Current Pediatric Reviews · doi:10.2174/157339608783565770 · Cited by 101

Innate immunity in transplant tolerance and rejection

Murphy, S. P., Porrett, P. M., & Turka, L. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01009.x · Cited by 101

Bacterial modulation of mucosal innate immunity

Kelly, D., & Conway, S. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.12.003 · Cited by 97

RNA-based therapies: A cog in the wheel of lung cancer defense

Κhan, P., Siddiqui, J. A., Lakshmanan, I., Ganti, A. K., Salgia, R., Jain, M., Batra, S. K., & Nasser, M. W. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01338-2 · Cited by 104

Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance

Ehlers, M., & Ravetch, J. V. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.006 · Cited by 98

Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery

Melamed, J. R., Hajj, K. A., Chaudhary, N., Strelkova, D., Arral, M. L., Pardi, N., Alameh, M., Miller, J. B., Farbiak, L., Siegwart, D. J., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.022 · Cited by 101

An introduction to Toll‐like receptors and their possible role in the initiation of labour

Patni, S., Flynn, P., Wynen, L., Seager, A. L., Morgan, G., WHITE, J. O., & Thornton, C. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01488.x · Cited by 96

The Danger Signal S100B Integrates Pathogen– and Danger–Sensing Pathways to Restrain Inflammation

Sorci, G., Giovannini, G., Riuzzi, F., Bonifazi, P., Zelante, T., Zagarella, S., Bistoni, F., Donato, R., & Romani, L. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001315 · Cited by 100

Toll‐like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology

Girling, J. E., & Hedger, M. P. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100086 · Cited by 96

Toll-like receptors and signalling in spermatogenesis and testicular responses to inflammation—a perspective

Hedger, M. P. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.01.010 · Cited by 102

Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy

Zhang, C., Ma, Y., Zhang, J., Kuo, J. C., Zhang, Z., Xie, H., Zhu, J., & Liu, T. (2022) · Molecules · doi:10.3390/molecules27061943 · Cited by 95

Evidence for Evolving Toll-IL-1 Receptor-Containing Adaptor Molecule Function in Vertebrates

Sullivan, C., Postlethwait, J. H., Lage, C. R., Millard, P. J., & Kim, C. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4517 · Cited by 95

Toll/Interleukin-1 Receptor Domain-Containing Adapter Inducing Interferon-β Mediates Microglial Phagocytosis of Degenerating Axons

Hosmane, S., Tegenge, M. A., Rajbhandari, L., Uapinyoying, P., Kumar, N. G., Thakor, N. V., & Venkatesan, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0203-12.2012 · Cited by 93

Recognition of Double-Stranded RNA and Regulation of Interferon Pathway by Toll-Like Receptor 10

Lee, S. M.-Y., Yip, T.-F., Yan, S., Jin, D., Wei, H., Guo, R., & Peiris, J. S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00516 · Cited by 93

NKG2D and cytotoxic effector function in tumor immune surveillance

Hayakawa, Y., & Smyth, M. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.005 · Cited by 93

Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses

Li, M., Li, Y., Peng, K., Wang, Y., Gong, T., Zhang, Z., He, Q., & Sun, X. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.019 · Cited by 91

Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid Promotes Wound Healing in Human and Murine Skin

Lin, Q., Wang, L., Lin, Y., Liu, X., Ren, X., Wen, S., Du, X., Lu, T., Su, S. Y., Yang, X., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.120 · Cited by 92

Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins

Angel, M., & Yanik, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011756 · Cited by 91

Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis

Cufi, P., Dragin, N., Weiss, J. M., Martínez‐Martínez, P., Baets, M. H. D., Roussin, R., Fadel, É., Berrih‐Aknin, S., & Panse, R. L. (2012) · Annals of Neurology · doi:10.1002/ana.23791 · Cited by 89

Identification of Toll-Like Receptor 3 as a Potential Therapeutic Target in Clear Cell Renal Cell Carcinoma

Morikawa, T., Sugiyama, A., Kume, H., Ota, S., Kashima, T. G., Tomita, K., Kitamura, T., Kodama, T., Fukayama, M., & Aburatani, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0603 · Cited by 91

Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation

Krasowska‐Zoladek, A., Banaszewska, M., Kraszpulski, M., & Konat, G. W. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21088 · Cited by 91

Extracellular RNA sensing by pattern recognition receptors

Tatematsu, M., Funami, K., Seya, T., & Matsumoto, M. (2018) · Journal of Innate Immunity · doi:10.1159/000494034 · Cited by 90

Frameworks for transformational breakthroughs in RNA-based medicines

Androsavich, J. R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00943-2 · Cited by 100

Expression of toll‐like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL‐8 release, and up‐regulation of NKG2D‐ligands

Schreiner, B., Voss, J. G., Wischhusen, J., Dombrowski, Y., Steinle, A., Lochmüller, H., Dalakas, M. C., Melms, A., & Wiendl, H. (2005) · The FASEB Journal · doi:10.1096/fj.05-4342fje · Cited by 96

The role of resident synovial cells in destructive arthritis

Ospelt, C., & Gay, S. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.01.004 · Cited by 88

Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation

Lai, C.-Y., Su, Y., Lin, K., Hsu, L.-C., & Chuang, T. (2017) · Journal of Immunology Research · doi:10.1155/2017/7807313 · Cited by 89

TLR3 and TLR4 expression in healthy and diseased human endometrium

Allhorn, S., Böing, C., Koch, A., Kimmig, R., & Gashaw, I. (2008) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-6-40 · Cited by 88

Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: Implication in Wallerian degeneration

Lee, H., Jo, E., Choi, S., Oh, S. B., Park, K., Kim, J. S., & Lee, S. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.108 · Cited by 88

Non-CpG-Containing Antisense 2′-Methoxyethyl Oligonucleotides Activate a Proinflammatory Response Independent of Toll-Like Receptor 9 or Myeloid Differentiation Factor 88

Senn, J. J., Burel, S. A., & Henry, S. P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084004 · Cited by 88

A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors

Sloane, J. A., Blitz, D., Margolin, Z. R., & Vartanian, T. K. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8094-x · Cited by 86

Differential Toll-like receptor-dependent collagenase expression in chondrocytes

Zhang, Q., Hui, W., Litherland, G. J., Barter, M. J., Davidson, R. K., Darrah, C., Donell, S. T., Clark, I. M., Cawston, T. E., Robinson, J. H., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.079574 · Cited by 85

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity

Uchida, S., Kataoka, K., & Itaka, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030137 · Cited by 90

A new developing class of gene delivery: messenger RNA-based therapeutics

Zhao, M., Ahern, J. O., Lyu, J., Pierucci, L., Zhou, D., & Wang, W. (2017) · Biomaterials Science · doi:10.1039/c7bm00712d · Cited by 95

“Endogenous adjuvant” activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60

Kelly, K. M., Zhuang, H., Nacionales, D. C., Scumpia, P. O., Lyons, R., Akaogi, J., Lee, P. Y., Williams, B. R. G., Yamamoto, M., Akira, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21819 · Cited by 86

Hyaluronan digestion controls DC migration from the skin

Muto, J., Morioka, Y., Yamasaki, K., Kim, M., Garcia, A., Carlin, A. F., Varki, A., & Gallo, R. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67947 · Cited by 84

Toll-like receptor polymorphisms and age-related macular degeneration

Edwards, A. O., Chen, D., Fridley, B. L., James, K. M., Wu, Y., Abecasis, G., Swaroop, A., Othman, M., Branham, K., Iyengar, S. K., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1378 · Cited by 84

Characterization of the ribonuclease activity on the skin surface

Probst, J., Brechtel, S., Scheel, B., Hoerr, I., Jung, G., Rammensee, H.-G., & Pascolo, S. (2006) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-4-4 · Cited by 84

Necrosis-dependent and independent signaling of the RIP kinases in inflammation

Moriwaki, K., & Chan, F. K.-M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.013 · Cited by 84

Dendritic cell‐based human immunodeficiency virus vaccine

Rinaldo, C. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02047.x · Cited by 90

Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3

So, E. Y., Kang, M. H., & Kim, B. (2006) · Glia · doi:10.1002/glia.20346 · Cited by 83

Role of Extracellular Damage-Associated Molecular Pattern Molecules (DAMPs) as Mediators of Persistent Pain

Kato, J., & Svensson, C. I. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.014 · Cited by 85

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy

Palanivelu, L., Liu, C., & Lin, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038226 · Cited by 86

A Comprehensive Analysis of Pattern Recognition Receptors in Normal and Inflamed Human Epidermis: Upregulation of Dectin-1 in Psoriasis

de Koning, H. D., Rodijk‐Olthuis, D., van Vlijmen‐Willems, I. M. J. J., Joosten, L. A. B., Netea, M. G., Schalkwijk, J., & Zeeuwen, P. L. J. M. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.196 · Cited by 84

Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression.

Aflatoonian, R., & Fazeli, A. (2008) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.03.014 · Cited by 78

The UDP-Glucose Receptor P2RY14 Triggers Innate Mucosal Immunity in the Female Reproductive Tract by Inducing IL-8

Arase, T., Uchida, H., Kajitani, T., Ono, M., Tamaki, K., Oda, H., Nishikawa, S., 各務, 真., Nagashima, T., Masuda, H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900001 · Cited by 83

The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets

Xu, W., Gao, L., Zheng, J., Li, T., Shao, A., Reis, C., Chen, S., & Zhang, J. (2018) · Cell Transplantation · doi:10.1177/0963689718773361 · Cited by 85

Innate Immune Regulation by Toll-Like Receptors in the Brain

Mallard, C. E. (2012) · ISRN Neurology · doi:10.5402/2012/701950 · Cited by 82

Pattern Recognition Molecules Activated by Chlamydia muridarum Infection of Cloned Murine Oviduct Epithelial Cell Lines

Derbigny, W. A., Kerr, M. S., & Johnson, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6065 · Cited by 81

Advances in Toll-like receptor biology: Modes of activation by diverse stimuli

Bryant, C. E., Gay, N. J., Heymans, S. R. B., Sacre, S. M., Schaefer, L., & Midwood, K. S. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1033511 · Cited by 80

Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3

Amarante, M. K., Oda, J. M. M., Reiche, E. M. V., Morimoto, H. K., Aoki, M. N., & Watanabe, M. A. E. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.303 · Cited by 7

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses

Tatematsu, M., Seya, T., & Matsumoto, M. (2014) · Biochemical Journal · doi:10.1042/bj20131492 · Cited by 77

Transcriptional signaling by double-stranded RNA: role of TLR3

Sen, G. C., & Sarkar, S. N. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 260

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 329